A to Z

Parkinson’s disease

The image shows microtubule disintegration in alzheimer's disease.

Featured Neurology Open Neuroscience Articles

·June 13, 2013·3 min read

A Peptide to Protect Brain Function

Researchers develop a protein called NAP which protects and restores nerve cell communication in some neurodegenerative diseases.

Featured Neurology

·October 18, 2017·2 min read

‘Cats-And-Dogs’ Test to Predict Dementia Among Parkinson’s Patients

A test that uses images of cats and dogs may prove to be a quick and effective method of predicting which patients in early stages of Parkinson's disease will develop dementia.

Featured Neurology Neuroscience Open Neuroscience Articles

·November 1, 2022·4 min read

‘A Silent Killer’: COVID-19 Shown to Trigger Inflammation in the Brain

COVID-19 infection activates the same inflammatory response in the brain as Parkinson's disease, a new study reports.

Featured Neurology Neuroscience

·March 13, 2020·5 min read

‘Natural killer’ cells could halt Parkinson’s progression

Natural killer cells may play a critical role in regulating and restraining neuroinflammation and protein clumping associated with Parkinson's disease.

Featured Neurology Neuroscience Open Neuroscience Articles

·May 6, 2022·4 min read

‘Stressed’ Cells Offer Clues to Eliminating Build-up of Toxic Proteins in Dementia

Study reveals a new mechanism that appears to reverse the build-up of protein aggregates by refolding them, rather than removing them.

Image shows a brain of an Alzheimer's patient.

Featured Genetics Neurology Open Neuroscience Articles

·March 9, 2017·6 min read

“Jumping Genes” May Set the Stage for Brain Cell Death in Alzheimer’s

Researchers have identified a mechanism that may explain how neurons falter during the earliest stages of Alzheimer's and other neurodegenerative diseases.

This shows a drawing of two faces looking at each other

Featured Genetics Neurology Neuroscience

·June 9, 2022·5 min read

A ‘Double Life’ for a Key Parkinson’s Disease Protein

The Parkinson's-associated protein alpha-synuclein appears to act as a "toggle switch" that helps control vesicle transportation and gene expression. In a diseased state, this delicate balance is broken. The findings have implications for the development of new treatments for Parkinson's disease.